T. Hauw The

Q: What Schools Are Affiliated With T. Hauw The

T. Hauw The is affiliated with the following schools: University of Groningen, Massachusetts General Hospital

T. Hauw The's AcademicInfluence.com Rankings

T. Hauw The

Philosophy

#8962

World Rank

#12449

Historical Rank

Logic

#5967

World Rank

#7433

Historical Rank

philosophy Degrees

T. Hauw The

Biology

#12239

World Rank

#15703

Historical Rank

Immunology

#814

World Rank

#837

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

T. Hauw The's Degrees

Doctorate Medicine Stanford University

Why Is T. Hauw The Influential?

(Suggest an Edit or Addition)

(See a Problem?)

T. Hauw The's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

AUTOANTIBODIES AGAINST NEUTROPHILS AND MONOCYTES: TOOL FOR DIAGNOSIS AND MARKER OF DISEASE ACTIVITY IN WEGENER'S GRANULOMATOSIS (1985) (1795)
Association between active Wegener's granulomatosis and anticytoplasmic antibodies. (1989) (547)
Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre (1990) (432)
Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leucocytes (1988) (395)
Fibroblasts, epithelial cells, endothelial cells and smooth muscle cells are major targets of human cytomegalovirus infection in lung and gastrointestinal tissues. (1995) (390)
Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. (1995) (371)
Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of posttransplant lymphoproliferative disease in high-risk patients. (2001) (332)
Conjugation of fluorescein isothiocyanate to antibodies. I. Experiments on the conditions of conjugation. (1970) (288)
Comparison between viremia and antigenemia for detection of cytomegalovirus in blood (1988) (286)
Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. (1990) (263)
Circulating cytomegalovirus (CMV)-infected endothelial cells in patients with an active CMV infection. (1993) (259)
Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. (1970) (238)
Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction. (1992) (219)
Association of autoantibodies to myeloperoxidase with different forms of vasculitis. (2010) (202)
Prevention of primary cytomegalovirus infection in patients with hematologic malignancies by intensive white cell depletion of blood products (1989) (181)
Anti-acetylcholine receptor antibodies in myasthenia gravis Part 1. Relation to clinical parameters in 250 patients (1983) (181)
Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation--a report of 130 consecutive patients. (1989) (174)
Tissue macrophages are infected by human cytomegalovirus in vivo. (1996) (162)
Characterization of three new variant type cell lines derived from small cell carcinoma of the lung. (1985) (161)
The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. (1992) (155)
Anti-acetylcholine receptor antibodies in myasthenia gravis Part 2. Clinical and serological follow-up of individual patients (1983) (141)
Selective MR imaging of labeled human peripheral blood mononuclear cells by liposome mediated incorporation of dextran‐magnetite particles (1993) (135)
Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication. (2002) (132)
Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis. (1991) (129)
The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. (1999) (128)
Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. (1991) (124)
Antinuclear antibodies in patients with Raynaud's phenomenon: clinical significance of anticentromere antibodies. (1982) (110)
The cytomegalovirus antigenemia assay: a plea for standardization. (1995) (103)
Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection. (1974) (100)
Phase I study of intravenously applied bispecific antibody in renal cell cancer patients receiving subcutaneous interleukin 2. (1994) (96)
Susceptibility to development of Mycobacterium ulcerans disease: review of possible risk factors (2001) (91)
Neuroendocrine differentiation antigen on human lung carcinoma and Kulchitski cells. (1985) (91)
Ultrastructural analysis of circulating cytomegalic cells in patients with active cytomegalovirus infection: evidence for virus production and endothelial origin. (1993) (82)
Presence of human cytomegalovirus (HCMV) immediate early mRNA but not ppUL83 (lower matrix protein pp65) mRNA in polymorphonuclear and mononuclear leukocytes during active HCMV infection. (1994) (82)
Frequent monitoring of Epstein-Barr virus DNA load in unfractionated whole blood is essential for early detection of post-transplant lymphoproliferative disease in lung transplant patients. (2001) (82)
Cytomegalovirus antigenemia: clinical correlations in transplant recipients and in persons with AIDS (1993) (80)
Immune response capacity after human splenic autotransplantation: restoration of response to individual pneumococcal vaccine subtypes. (1999) (77)
HERPES-VIRUS IMMUNITY AND ACUTE GRAFT-VERSUS-HOST DISEASE (1987) (72)
Cytomegalovirus infection after organ transplantation: an update with special emphasis on renal transplantation (1989) (70)
Detection of immunoglobulin M and G antibodies against cytomegalovirus early and late antigens by enzyme-linked immunosorbent assay (1984) (68)
Direct visualisation and quantification of cellular cytotoxicity using two colour flourescence. (1992) (68)
Recovery of T cell subsets after autologous bone marrow transplantation is mainly due to proliferation of mature T cells in the graft. (1985) (67)
Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. (1997) (67)
A standard method for DNCB sensitization testing in patients with neoplasms (1974) (66)
Systemic involvement and immunologic findings in patients presenting with Raynaud's phenomenon. (1980) (65)
Evidence for an increased rate of bacterial infections in liver transplant patients with cytomegalovirus infection. (1996) (63)
Abdominal obesity and smoking are important determinants of C-reactive protein in renal transplant recipients. (2005) (61)
Cytomegalovirus antigenemia. (1990) (61)
The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. (1985) (60)
Quantitative measurement of cytomegalovirus‐specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection (1990) (59)
Early serodiagnosis of acute human cytomegalovirus infection by enzyme-linked immunosorbent assay using recombinant antigens (1994) (58)
Increased frequency of B8/DR3 in scleroderma and association of the haplotype with impaired cellular immune response. (1981) (57)
Cytomegalovirus hepatitis in normal and immune compromised hosts. (2008) (55)
Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis. Clinical correlations. (1991) (54)
Prediction of recurrent cytomegalovirus disease after treatment with ganciclovir in solid-organ transplant recipients. (1993) (51)
Rapid detection of infectious cytomegalovirus in blood with the aid of monoclonal antibodies (1987) (51)
Demonstration of IgM cytomegalovirus-antibodies as an aid to early diagnosis in adults. (1970) (50)
The value of prospective monitoring of Epstein–Barr virus DNA in blood samples of pediatric liver transplant recipients (2004) (49)
Local immune complexes and inflammatory response in patients with chronic interstitial pulmonary disorders associated with collagen vascular diseases. (1984) (48)
Early detection of active cytomegalovirus (CMV) infection after heart and kidney transplantation by testing for immediate early antigenemia and influence of cellular immunity on the occurrence of CMV infection (1990) (48)
Insulin resistance as putative cause of chronic renal transplant dysfunction. (2003) (47)
Viral Load in Breast Milk Correlates with Transmission of Human Cytomegalovirus to Preterm Neonates, but Lactoferrin Concentrations Do Not (2001) (46)
Quantitation of immunosuppression by flow cytometric measurement of the capacity of T cells for interleukin-2 production. (1998) (46)
Antibodies to epstein‐barr virus, cytomegalovirus, and australia antigen in hodgkin's disease (1974) (45)
Decreased nailfold capillary density in Raynaud's phenomenon: a reflection of immunologically mediated local and systemic vascular disease? (1985) (45)
Coronary Angioplasty Induces Rise inChlamydia pneumoniae-Specific Antibodies (1999) (45)
Uninfected and cytomegalic endothelial cells in blood during cytomegalovirus infection: effect of acute rejection. (2000) (44)
Viral chemokine-modulatory proteins: tools and targets. (2005) (44)
The human cytomegalovirus-encoded receptor US28 increases the activity of the major immediate-early promoter/enhancer. (2006) (43)
B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis. (1983) (43)
Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipients. (1995) (42)
Platelet activation, fibrinolytic activity and circulating immune complexes in Raynaud's phenomenon. (1982) (41)
Plasma lactoferrin levels are decreased in end-stage AIDS patients. (1999) (41)
The influence of cytomegalovirus carrier status on lymphocyte subsets and natural immunity. (1987) (41)
Expression of class II major histocompatibility complex antigens on alveolar epithelium in interstitial lung disease: relevance to pathogenesis of idiopathic pulmonary fibrosis. (1987) (40)
Low HLA‐DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake (1999) (39)
Detection of small cell lung cancer metastases in bone marrow aspirates using monoclonal antibody directed against neuroendocrine differentiation antigen. (1988) (39)
In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin. (1983) (38)
Monitoring for cytomegalovirus after organ transplantation: a clinical perspective. (1993) (38)
Immunoperoxidase staining on frozen tissue sections as a first screening assay in the preparation of monoclonal antibodies directed against small cell carcinoma of the lung. (1984) (38)
Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. (1977) (38)
Immobilised metal-ion affinity chromatography purification of histidine-tagged recombinant proteins: a wash step with a low concentration of EDTA. (2001) (38)
Cytomegalovirus infection increases the expression and activity of ecto‐ATPase (CD39) and ecto‐5′nucleotidase (CD73) on endothelial cells (2001) (38)
Anti-acetylcholine receptor antibodies in myasthenia gravis Part 3. The effect of thymectomy (1985) (37)
Antigen test for early diagnosis of active cytomegalovirus infection in heart transplant recipients. (1988) (35)
Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins (1995) (33)
The influence of therapy with azathioprine and prednisone on the immune system of kidney transplant recipients. (1981) (33)
Monitoring antigenemia is useful in guiding treatment of severe cytomegalovirus disease after organ transplantation (1992) (32)
HLA-DR expression on monocytes and systemic inflammation in patients with ruptured abdominal aortic aneurysms (2006) (32)
Acute rejection before cytomegalovirus infection enhances von Willebrand factor and soluble VCAM-1 in blood. (2000) (32)
PNEUMATOSIS INTESTINALIS IN PATIENTS AFTER CADAVERIC KIDNEY TRANSPLANTATION POSSIBLE RELATIONSHIP WITH AN ACTIVE CYTOMEGALOVIRUS INFECTION (1984) (32)
Steroid-responsive interstitial pulmonary disease in systemic sclerosis. Monitoring by bronchoalveolar lavage. (1984) (31)
Dissemination of Rat Cytomegalovirus through Infected Granulocytes and Monocytes In Vitro and In Vivo (2003) (31)
Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. (1989) (31)
Pulmonary involvement during cytomegalovirus infection in immunosuppressed patients (2003) (30)
Cryopreservation of newly formed hybridomas. (1983) (29)
Antibodies against membrane antigens of cytomegalovirus infected cells in sera of patients with a cytomegalovirus infection. (1972) (29)
The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection (1995) (29)
Cytomegalovirus antigenemia assay: identification of the viral antigen as the lower matrix protein pp65. (1992) (28)
Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity? (1984) (28)
Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma. (1980) (27)
Antibody responses in vivo in chromosome instability syndromes with immunodeficiency. (1984) (27)
Expression of class II MHC antigens on alveolar epithelium in fibrosing alveolitis. (1987) (27)
Increased intestinal permeability during cytomegalovirus infection in renal transplant recipients (1996) (27)
Local antitumour treatment in carcinoma patients with bispecific-monoclonal-antibody-redirected T cells (1993) (25)
HLA-B8/DR3 phenotype and the primary immune response. (1985) (24)
Cytomegalovirus-directed lymphocyte reactivity in healthy adults tested by a CMV-induced lymphocyte transformation test. (1977) (24)
Quantitative Epstein‐Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post‐transplant lymphoproliferative disease (2003) (24)
Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report (2002) (24)
Effects of changing immunosuppressive regimen on the incidence, duration, and viral load of cytomegalovirus infection in renal transplantation: a single center report (2002) (24)
Killing of human cytomegalovirus-infected fibroblasts by antiviral antibody and complement. (1986) (23)
Quantification of immunosuppression by flow cytometric measurement of intracellular cytokine synthesis (1998) (23)
SURFACE ANTIGENS ON CULTURED MALIGNANT MELANOMA CELLS AS DETECTED BY A MEMBRANE IMMUNOFLUORESCENCE METHOD WITH HUMAN SERA. LACK OF TUMOR‐SPECIFIC REACTIONS ON MELANOMA LINES * (1975) (23)
Donor-specific hyporeactivity after liver transplantation: prominent decreases in donor-specific cytotoxic T lymphocyte precursor frequencies independent of changes in helper T lymphocyte precursor frequencies or suppressor cell activity. (1998) (23)
Do food antigens play a role in the pathogenesis of some cases of human glomerulonephritis? (1983) (22)
In vivo antinuclear antibodies (ANA) in biopsies of normal skin: diagnostic significance and relation to serum ANA. (1983) (21)
Use of a Fragment of Glycoprotein G-2 Produced in the Baculovirus Expression System for Detecting Herpes Simplex Virus Type 2-Specific Antibodies (2002) (21)
Uptake of pp65 in in vitro Generated pp65-Positive Polymorphonuclear Cells Mediated by Phagocytosis and Cell Fusion? (2001) (21)
Immune reactivity of women on hormonal contraceptives: dinitrochlorobenzene sensitization test and skin reactivity to irritants. (1979) (21)
Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients. (2001) (21)
Reduction of EGP‐2‐positive pulmonary metastases by bispecific‐antibody‐redirected T cells in an immunocompetent rat model (1995) (20)
Detection of cytomegalovirus antigens and DNA in tissues fixed in formaldehyde. (1989) (20)
Cytomegalovirus infection associated with a decreased proliferative capacity and increased rate of apoptosis of peripheral blood lymphocytes. (1995) (20)
Quantitation of antibodies to nucleoribonucleoprotein by ELISA: relation between antibody levels and disease activity in patients with connective tissue disease. (1985) (20)
Class-specific antibody titres (ELISA) against the primary immunogen Helix pomatia haemocyanin (HPH) in man. (1978) (20)
Our approach towards developing a specific tumour-targeted MRI contrast agent for the brain. (1993) (20)
Immunological investigations in individuals with selective IgA deficiency. (1986) (20)
Suppression of DNA synthesis by Con A-activated human lymphocytes: Stimulation by con A bound to non-T cells unless removed after activation. (1977) (20)
Direct Quantification of Human Cytomegalovirus Immediate-Early and Late mRNA Levels in Blood of Lung Transplant Recipients by Competitive Nucleic Acid Sequence-Based Amplification (2001) (20)
Immune complexes in peripheral blood polymorphonuclear leucocytes of patients with Raynaud's phenomenon. (1979) (19)
Fluctuations in anti-nRNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response. (1986) (19)
Circulating cytomegalovirus-infected endothelial cells after renal transplantation: possible clue to pathophysiology? (1995) (19)
Immune phagocytosis in vivo of human malignant melanoma cells. (2009) (19)
Suppression of DNA synthesis by con A-activated human lymphocytes: role of monocytes in con A-induced suppression. (1980) (19)
Immune complexes in peripheral blood polymorphonuclear leucocytes of malignant melanoma patients. (1978) (19)
Humoral and cell‐mediated immune response in patients with malignant melanoma. I. In vitro lymphocyte reactivity to pha and antigens following immunization (1975) (18)
HLA-DRw6 as a risk factor for active cytomegalovirus but not for herpes simplex virus infection after renal allograft transplantation. (1985) (18)
Plasma exchange in Guillain-Barré syndrome (1981) (18)
INCA: software for consort 30 analysis of flow cytometric calcium determinations. (1989) (17)
A study of the cellular and humoral immune response in patients with myelofibrosis. (2008) (17)
Cytomegalovirus immunity and T lymphocytes in bone marrow donors and acute graft-versus-host disease. (1986) (16)
Natural infection with herpes simplex virus type 1 (HSV-1) induces humoral and T cell responses to the HSV-1 glycoprotein H:L complex. (2000) (16)
The modulation of angiogenesis in the foreign body response by the poxviral protein M-T7. (2005) (16)
Kinetics of US28 gene expression during active human cytomegalovirus infection in lung-transplant recipients. (2006) (16)
Effect of B‐cell receptor engagement on CD40‐stimulated B cells (1997) (16)
Antinuclear and antinative DNA antibodies during captopril treatment. (2009) (16)
T-lymphocyte number and function and the course of hepatitis B in hemodialysis patients (1976) (15)
Primary cytomegalovirus infection and its prevention after autologous bone marrow transplantation. (1985) (15)
Adjuvant immunotherapy with BCG in squamous-cell bronchial carcinoma. Immune-reactivity in relation to immunostimulation (preliminary results in a controlled trial) (1978) (15)
Cytomegalovirus immunity in allogeneic marrow grafting. (1985) (15)
Progressive obliterative bronchiolitis in a patient with rheumatoid arthritis. (1982) (15)
Cellular and humoral parameters for vascular damage in blood during cytomegalovirus infections. (2001) (15)
Epidermodysplasia verruciformis. Skin carcinoma containing human papillomavirus type 5 DNA sequences and primary hepatocellular carcinoma associated with chronic hepatitis B virus infection in a patient. (1986) (14)
Human cytomegalovirus: a viral complication in transplantation. (1998) (14)
Cytomegalovirus antigenemia assay (1991) (14)
IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins. (1996) (14)
Discordance of Epstein-Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity. (1978) (14)
A Sensitive Method for Quantifying Cytomegalic Endothelial Cells in Peripheral Blood from Cytomegalovirus-Infected Patients (1998) (14)
High level expression and secretion of truncated forms of herpes simplex virus type 1 and type 2 glycoprotein D by the methylotrophic yeast Pichia pastoris. (2002) (14)
Detection and isolation of antigen-specific B cells by the fluorescence activated cell sorter (FACS). (1989) (14)
Immunomodulatory effects of intravenous BIS-1 F(ab')2 administration in renal cell cancer patients. (1995) (14)
Herpes virus infections after orthotopic liver transplantation. (1987) (14)
Comparison of the Murex Hybrid Capture CMV DNA (v2.0) assay and the pp65 CMV antigenemia test for the detection and quantitation of CMV in blood samples from immunocompromised patients. (1999) (14)
Complement activation during an active cytomegalovirus infection after renal transplantation: due to circulating immune complexes or alternative pathway activation? (1989) (14)
Human fibroblasts, a convenient nuclear substrate for detection of anti-nuclear antibodies including anti-centromere antibodies. (1983) (14)
Donor or recipient origin of post transplant lymphoproliferative disease after lung transplantation. (2001) (14)
Comparison of in vitro lymphocyte proliferations induced by cytomegalovirus-infected human fibroblasts and cell-free cytomegalovirus. (1980) (13)
CMV infection after organ transplantation: immunopathological and clinical aspects. (1994) (13)
Recent advances in the diagnosis of active cytomegalovirus infection after organ transplantation. (1990) (13)
The primary immune response in patients with selective IgA deficiency. (1983) (13)
Identification of three indolic compounds in a pigmented-melanoma cell-culture supernatant by gas chromatography-mass spectrometry (2004) (13)
Cytomegalovirus infection after renal transplantation. Pulmonary dysfunction measured by decreased diffusing capacity for carbon monoxide in patients with symptomatic and asymptomatic infection. (1987) (13)
Quo vadis? The clinical dilemma of simultaneous cytomegalovirus infection and steroid-resistant rejection. (1991) (12)
The primary immune response in bronchial asthma. I. A kinetic study of Helix pomatia hemocyanin-specific IgE, IgG, IgA, and IgM antibody responses in patients with asthma and in matched controls. (1985) (12)
A longitudinal study on the effects of azathioprine and high doses of prednisone on the immune system of kidney-transplant recipients. (1982) (12)
Pneumatosis intestinalis in patients after cadaveric kidney transplantation: possible relationship with an active cytomegalovirus infection. (1985) (12)
In vitro T-cell dependent B-cell activity in myasthenia gravis. (1985) (12)
Marrow donor immunity to herpes simplex virus: association with acute graft-versus-host disease. (1987) (12)
Fc‐receptor function after human splenic autotransplantation (1996) (12)
Towards Standardization of the Human Cytomegalovirus Antigenemia Assay (2000) (11)
Radioimmunodetection of human small cell lung carcinoma xenografts in the nude rat using 111in-labelled monoclonal antibody MOC-31. (1993) (11)
Reversible hypogammaglobulinaemia after diphenylhydantoin and hydroxyzine therapy. (1974) (11)
Domains of glycoprotein H of herpes simplex virus type 1 involved in complex formation with glycoprotein L. (1999) (11)
Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation (1996) (10)
Cytomegalovirus early and late membrane antigens detected by antibodies in human convalescent sera (1985) (10)
Evidence for pulmonary dysfunction in all patients with symptomatic and asymptomatic cytomegalovirus (CMV) infection after renal transplantation. (1989) (10)
Magnetite as a potent contrast-enhancing agent in magnetic resonance imaging to visualize blood-brain barrier disruption. (1993) (10)
PHA-induced cytotoxicity of human lymphocytes against adherent hela cells. (1978) (10)
Preemptive therapy with gancyclovir for early high-risk CMV infection allows effective treatment with antithymocyte globulin of steroid-resistant rejection after renal transplantation. (1993) (10)
Acute cytomegalovirus infection and the host immune response. II. Relationship of suppressed in vitro lymphocyte reactivity to bacterial recall antigens and mitogens with the development of cytomegalovirus-induced lymphocyte reactivity. (1980) (10)
Immune reactivity of women on hormonal contraceptives. Phytohemagglutinin and concanavalin-A induced lymphocyte response. (1980) (10)
The role of apoptosis in bispecific antibody-mediated T-cell cytotoxicity. (1996) (9)
Humoral Immune Response to Human Cytomegalovirus in Patients Undergoing Percutaneous Transluminal Coronary Angioplasty (1999) (9)
Early sCD8 plasma levels during subcutaneous rIl-2 therapy in patients with renal cell carcinoma correlate with response. (1993) (9)
Intracerebral and subcutaneous xenografts of human SCLC in the nude rat: comparison of monoclonal antibody localization and tumor infiltrating lymphocytes (1993) (9)
Cytomegalovirus pneumonitis after kidney transplantation is not caused by plugging of cytomegalic endothelial cells only (1999) (9)
An improved immunocytochemical method for the detection of human cytomegalovirus antigens in peripheral blood leucocytes (2004) (9)
Cytomegalovirus‐specific antibodies to an immediate early antigen and a late membrane antigen and their possible role in controlling secondary cytomegalovirus infection (1991) (9)
Efficient generation of human anti-cytomegalovirus IgG monoclonal antibodies from preselected antigen-specific B cells. (1993) (8)
Plasma Exchange in Five Patients with Acute Guillain Barré syndrome (1981) (8)
Immunological dysfunction in paroxysmal nocturnal haemoglobinuria. (1981) (8)
The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. (1978) (8)
Cyclosporine A is associated with a shift of the Th1/Th2 balance in liver transplant patients. (1998) (8)
Human fibroblasts as a substrate for titration of ANA. (1985) (8)
Cryosurgery in metastatic malignant melanoma. (1975) (7)
Quantification of low frequency white blood cells expressing human cytomegalovirus antigen by image cytometry. (1994) (7)
Systemic autoimmune disease and Raynaud's phenomenon: a common, immunologically mediated, vascular basis? (1984) (7)
Passage of DMP across a disrupted BBB in the context of antibody-mediated MR imaging of brain metastases. (1990) (7)
HLA-B8 in Raynaud's phenomenon. (2008) (7)
COMPLEMENT ACTIVATION ASSOCIATED WITH ACTIVE CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT PATIENTS, AND ITS ABSENCE IN TRANSPLANT REJECTION EPISODES (1985) (7)
Acute cytomegalovirus infection and the host immune response. I. Development and maintenance of cytomegalovirus (CMV) induced in vitro lymphocyte reactivity and its relationship to the production of CMV antibodies. (1980) (7)
Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma (1977) (7)
Increased production of antigen-specific B lymphocytes during in vitro immunization using carrier-specific T helper hybridomas. (1992) (7)
Sensitivity to hydrocortisone is a relevant factor in the immunoendocrine relationship. I. The cell-mediated immune response in relation to blood levels and in vitro immunosuppressive effects of hydrocortisone in patients with asthma and healthy control subjects. (1986) (6)
Overcoming the Problem of Cytomegalovirus Infection after Organ Transplantation: Calling for Heracles? (2000) (6)
Peripheral blood lymphocyte number and phenotype prior to therapy correlate with response in subcutaneously applied rIL-2 therapy of renal cell carcinoma. (1992) (6)
Cell-mediated immune response in patients with bronchial carcinoma. Relation between clinical parameters and various immunological tests for immune status investigation. (1979) (6)
IgA-nephropathy: triumph of immunology or misconception? (1984) (6)
Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. I. Prolonged suppression of in vitro lymphocyte responses against CMV infected fibroblasts related to previous secondary CMV infection. (1985) (6)
Maintenance of cytomegalovirus (CMV) latency and host immune responses of long term renal allograft survivors. II. Secondary CMV infections associated with impaired in vitro proliferative responses to mitogens, allogeneic lymphocytes and CMV infected cells. (1985) (6)
The human immune response to alpha-haemocyanin of Helix pomatia. (1973) (6)
The cellular immune response to cell-associated and cell-free cytomegalovirus (CMV) antigens after primary CMV-infection in non-immunocompromised hosts: development and maintenance of CMV-latency and its influence on immunocompetence. (1988) (6)
Characterization of the soluble immune complexes that are detected by three different techniques. (1986) (6)
Immune Response in Asymptomatic Paraproteinemia (1976) (5)
A sensitive method to measure PHA-induced cytotoxicity to adherent target cells using [3H]uridine as a terminal label. (1982) (5)
Reticuloendothelial Fc receptor function in SLE patients. II. Associations with humoral immune response parameters in vivo and in vitro. (1984) (5)
HLA-Dr-expressing CD8bright cells are only temporarily present in the circulation during subcutaneous recombinant interleukin-2 therapy in renal cell carcinoma patients (2005) (5)
Prior Cytomegalovirus Infection Does Not Predict Clinical Outcome after Percutaneous Transluminal Coronary Angioplasty (1999) (5)
Immunoglobulin A-specific serodiagnosis of acute human cytomegalovirus infection by using recombinant viral antigens (1996) (5)
Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins. (1995) (5)
Isolation of Highly Purified Lymphocyte Subsets for Functional Studies by Means of an Indirect Rosette Technique (1985) (5)
LAMA tumor in the rat as an experimental model for pre-B-cell leukemia. (1989) (4)
Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients. (1989) (4)
A stimulatory role for cytomegalovirus (CMV) antibodies in CMV-specific lymphocyte proliferation in vitro. (1983) (4)
Prediction of the inhibition of IL-2 production by calcineurin inhibitors. (2001) (4)
Symptomatic cytomegalovirus (CMV) infections identified by image cytometry and other parameters for CMV infection (1990) (4)
B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease. (1988) (4)
Donor-specific immunological non-responsiveness after liver transplantation (1998) (4)
Antibody responses to human cytomegalovirus‐specific polypeptides studied by immunoblotting in relation to viral load during cytomegalovirus infection (1993) (4)
Cell‐mediated immune reactivity in multiple sclerosis (1981) (4)
Lymphocyte reactivity in infectious mononucleosis. (1980) (3)
Early identification of patients at high risk of severe cytomegalovirus disease after renal transplantation using the immediate early antigenemia assay. (1990) (3)
Immunofluorescence for detection of antibodies against human cytomegalovirus-induced membrane antigens (1986) (3)
Patients at risk for post-transplant lymphoproliferative disease can be identified in the first months after lung transplantation by quantitative-competitive-EBV-PCR. (2001) (3)
Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma. (1980) (3)
Lessons from cytomegalovirus disease in pediatric kidney transplantation. (1999) (3)
Cellular immunocompetence in asymptomatic paraproteinaemia. (2009) (3)
Cellular immune activation reflects antiviral immunity and is a favorable prognostic marker in patients with cytomegalovirus infection. (1993) (3)
[The DNZB-test for the determination of cellular immune reactivity in patients with neoplasms]. (1973) (3)
Subclinical pneumonitis during cytomegalovirus infection after kidney transplantation. (1999) (3)
Characterization of membrane antigens on human cytomegalovirus-infected fibroblasts recognized by human antibodies (1989) (2)
Eular workshop on Rheumatology Research (1982) (2)
Primary immune response to Helix pomatia haemocyanin in malignant melanoma. Relationship between 19S and 7S antibody response and in vitro lymphocyte transformation. (1976) (2)
Raynaud's phenomenon: factors of prognostic significance for the development of connective tissue disease. Relevance of vascular and immunological tests. (1986) (2)
The diagnostic use of monoclonal antibodies against small cell lung carcinoma cells. (1985) (2)
Intermediate filament expression in small cell lung cancer; poor correlation to in vitro data. (1987) (2)
Impaired Antigen‐Specific B‐Cell Response and Altered Splenic Microstructure in Mice Following Continuous Administration of IL‐4 In Vivo (1995) (2)
Determination of human antibodies to specific antigens of cytomegalovirus using an antigen capture immunoassay. (1989) (2)
Kinetics of US 28 Gene Expression during Active Human Cytomegalovirus Infection in Lung-Transplant Recipients (2006) (2)
[Cytomegalovirus infection in adults]. (1970) (2)
Prolonged continuous infusion of low-dose rIL-2. (1994) (2)
Prophylactic application of an anti-cytomegalovirus hyperimmunoglobulin in allogeneic bone marrow transplant recipients. (1987) (2)
Studies on the Induction of Antigen-Specific Antibody in Anti-CD40 Cultured Human B Lymphocytes (1998) (1)
Defective stimulating capacity of leukocytes in mixed leukocyte culture in constitutional aplastic anemia caused by suppressor T cells. A case study. (1980) (1)
Some recent developments in human tumour immunology. (1972) (1)
When to perform a renal biopsy in systemic lupus erythematosus (SLE)? A retrospective analysis of the correlation between morphological findings and clinical data at the time of biopsy. (1981) (1)
Impaired lymphocyte function and neutrophil damage during the first hours of hemodialysis. (1977) (1)
High immune responsiveness in a family with multiple paraproteinaemia and autoimmune thyroid disease. (2009) (1)
The Production of Monoclonal Antibodies (2019) (0)
CYTOMEGALOVIRUS IMMUNITY IN ALLOGENEIC MARROW GRAFTING1 (1985) (0)
Detection of cytomegalovirus (CMV) immediate early antigens in peripheral blood leukocytes during active CMV infection. (1991) (0)
[Raynaud's phenomenon, a paraneoplastic syndrome?]. (1978) (0)
CYTOMEGALOVIRUS (CMV)-SPECIFIC ANTIBODIES INHIBIT THE IN VITRO GENERATION OF CMV PP65 ANTIGENEMIA IN POLYMORPHONUCLEAR CELLS (2000) (0)
NIEHS, UNC and Duke Instate Training Program (1994) (0)
The primary immune response of patients with different stages of squamous-cell bronchial carcinoma. Class specific antibody response and in-vitro lymphocyte stimulation after primary immunization with Helix pomatia hemocyanin. (1979) (0)
Class- and subclass-specific antibody response to hemocyanin in nonmalignant paraproteinemia. (1979) (0)
Immunoglobulin classes in local immune complexes recovered by bronchoalveolar lavage in collagen vascular diseases (2007) (0)
CHAPTER 7 EARLY POST-TRAUMATIC THROMBOCYTOPENIA IS NOT AFFECTED BY HIGH-DOSE METHYLPREDNISOLONE (2001) (0)
Persistence of cytotoxic T lymphocyte reactivity against donor antigens is a prognostic marker for chronic rejection after liver transplantation (1998) (0)
THE METABOLIC SYNDROME IS ASSOCIATED WITH IMPAIRMENT OF LONG-TERM RENAL GRAFT FUNCTION: NOT ALL COMPONENT CRITERIA CONTRIBUTE EQUALLY. (2004) (0)
Lymphocyte characteristics and function in paroxysmal nocturnal haemoglobinuria (1983) (0)
[Familial examinations for the presence of atypical cholinesterase]. (1975) (0)
Legionella pneumophila pneumonia associated with reactivation of cytomegalovirus infection (1985) (0)
Chapter 10 Epstein-Barr virus reactivation and lung transplant dysfunction (2006) (0)
Epstein-Barr virus in human disease. (1973) (0)
Abstracts of papers and posters Meeting on Pharmaceutical Sciences (1993) (0)
Concentrations Do Not to Preterm Neonates , but Lactoferrin Transmission of Human Cytomegalovirus Viral Load in Breast Milk Correlates with (2001) (0)
[Herpes simplex virus type 2 and cervix cancer]. (1978) (0)
Paroxysmal nocturnal haemoglobinuria. (1983) (0)
CMV antigenemia as diagnostic tool for diagnosing active cytomegalovirus infection. (1991) (0)
Phytohemagglutin-induced lymphocyte cytotoxicity in hemodialysis patients with hepatitis B virus infection. (1981) (0)
Donor‐specific immunological non‐responsiveness after liver transplantation (1998) (0)
Hodgkin's disease and herpes viruses. (1976) (0)
Immunological aspects of melanomas [proceedings]. (1977) (0)
Herpes virus immunity and acute graft-versus-host disease. (1987) (0)
CHAPTER 5 HLA-DR expression on monocytes and systemic inflammation with ruptured abdominal aortic aneurysms (2009) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With T. Hauw The?

T. Hauw The is affiliated with the following schools:

T. Hauw The's Academic­Influence.com Rankings

T. Hauw The's Degrees

Why Is T. Hauw The Influential?

T. Hauw The's Published Works

Published Works

What Schools Are Affiliated With T. Hauw The?

T. Hauw The's AcademicInfluence.com Rankings